Core Insights - The article discusses the IPO of Chando, a leading Chinese beauty brand, which marks a significant step in its capital journey after over 20 years in the market [1] - Chando has evolved from a channel-focused brand to one that aims for digital and refined management, seeking to establish a strong foothold in the competitive beauty market [6][12] Group 1: Company History and Development - Chando was founded in 2001, capitalizing on the gap in the Chinese cosmetics market, particularly in the CS channel [2] - The brand quickly became a leader in the CS channel, achieving significant growth and establishing itself as a benchmark for domestic products [2][3] - By 2010, Chando had successfully entered over 2,600 supermarkets, solidifying its position as a "national brand benchmark" [3] Group 2: Financial Performance - Chando's revenue has shown steady growth, with projected revenues of 42.92 billion, 44.42 billion, and 46.01 billion CNY from 2022 to 2024, and 24.48 billion CNY in the first half of 2025, reflecting a 6.4% year-on-year increase [6][7] - Despite a gross margin increase from 66.5% in 2022 to 70.1% in the first half of 2025, its net profit has fluctuated, with figures of 1.39 billion, 3.02 billion, and 1.90 billion CNY from 2022 to 2024 [7] - Chando's compound annual growth rate from 2022 to 2025 is only 3.5%, which is below the industry average, indicating challenges in maintaining competitive growth [7][10] Group 3: Market Position and Challenges - Chando's reliance on a single brand for over 94% of its revenue poses risks, especially as competitors leverage multi-brand strategies to capture diverse consumer segments [10] - The company has faced challenges in balancing marketing and R&D investments, with marketing expenses significantly outpacing R&D spending [10][11] - The competitive landscape is intensifying, with other brands achieving higher growth rates, highlighting Chando's need for strategic adjustments [7][10] Group 4: Future Prospects and Strategic Moves - The recent IPO and investment from L'Oréal are seen as pivotal for Chando, providing opportunities to enhance DTC capabilities, expand brand offerings, and increase R&D investments [11][12] - L'Oréal's involvement is expected to bolster Chando's product development and international expansion efforts, potentially leading to a more resilient brand ecosystem [11][12] - The company aims to address its growth uncertainties by diversifying its brand portfolio and improving its R&D focus, which are critical for long-term competitiveness [12]

Core Viewpoint - The article discusses the upcoming IPO of China's beauty brand "Chando" and its significance in the market, highlighting its growth and the strategic moves made by its parent company, Jala Group, led by founder Zheng Chunying [1][4]. Group 1: Company Overview - Chando, a leading Chinese beauty brand, has applied for a listing on the Hong Kong Stock Exchange, with Huatai International and UBS serving as joint sponsors [1]. - Founded by Zheng Chunying in 2001, Chando has expanded its presence across China, with over 62,700 retail points and more than 45,000 stores nationwide [5]. - The company operates a multi-brand matrix, including Chando, Pechoin, Meisu, and others, covering skincare, makeup, and personal care products [5]. Group 2: Financial Performance - Chando's revenue has shown consistent growth, with figures of 4.292 billion yuan, 4.442 billion yuan, 4.601 billion yuan, and 2.448 billion yuan for the years 2022 to the first half of 2025, respectively, with a year-on-year growth of 6.4% in the first half of 2025 [5][6]. - The company's net profit for the same periods was 139 million yuan, 302 million yuan, 190 million yuan, and 191 million yuan, indicating a stable profit trajectory [5]. Group 3: Market Position and Strategy - Chando ranks as the third-largest domestic cosmetics group in China by retail sales in 2024, with its brand being the second-largest among domestic brands, following Pechoin [5]. - The growth in revenue is attributed to the expansion of online channels, with online sales increasing from 59.7% in 2022 to 68.8% in the first half of 2025 [6]. - The company aims to enhance its direct-to-consumer (DTC) capabilities and improve the synergy between online and offline sales networks through the funds raised from the IPO [10]. Group 4: Ownership and Corporate Structure - Zheng Chunying and family hold approximately 87.82% of the voting rights in Chando, following a red-chip restructuring to facilitate the IPO [9]. - The company has a strategic partnership with L'Oréal, which holds a 6.67% stake in Chando [10].

Core Viewpoint - Chando Global Holdings Limited, a Chinese beauty unicorn, has applied for a listing on the Hong Kong Stock Exchange, marking a significant milestone for the company and its founder, Zheng Chunying, after 24 years in the capital market [1][3]. Group 1: Company Overview - Founded in 2001 by Zheng Chunying, Chando has grown from a beauty chain in Northeast China to a major player in the beauty industry, launching brands like "Meisu" and flagship brand "Chando" [3]. - Chando has established a multi-brand matrix, including five main brands: Chando, Peffy, Meisu, Chunxia, and Jichu, covering skincare, color cosmetics, and personal care categories [3]. - As of 2024, Chando is the third-largest domestic cosmetics group in China by retail sales, with its single brand ranking second among domestic brands, just below Pechoin [3]. Group 2: Financial Performance - Chando's revenue has shown consistent growth, with reported revenues of 4.292 billion, 4.442 billion, 4.601 billion, and 2.448 billion yuan for the years 2022 to 2025 H1, respectively, with a year-on-year growth of 6.4% in the first half of 2025 [3][4]. - The net profit for the same periods was 139 million, 302 million, 190 million, and 191 million yuan, indicating a stable profit trajectory [3]. Group 3: Market Position and Strategy - The growth in revenue is primarily attributed to the expansion of online channels and an increase in the number of offline retailers, with online revenue share rising from 59.7% in 2022 to 68.8% in the first half of 2025 [4]. - Chando's gross margin improved from 66.5% to 70.1%, although it remains lower than some high-end competitors, indicating potential for further premiumization [4]. Group 4: IPO and Future Plans - The IPO proceeds will be used to enhance direct-to-consumer capabilities, improve online and offline sales synergy, expand the multi-brand matrix, invest in R&D, and strengthen digital capabilities in membership, supply chain, and sales management [7]. - The company aims to enhance its production facilities and expand its international market presence to increase brand recognition and penetration [7].

Investment Rating - The industry investment rating is "Positive" (maintained) [1] Core Viewpoints - The report highlights the strong performance of the retail and beauty sectors, with a focus on the growth potential of domestic brands in the beauty industry [6][44] - The medical beauty segment is expected to see new growth drivers from innovative products, while the cosmetics sector is benefiting from the rise of domestic brands and consumer trends towards self-care [6][44] Summary by Sections 1. Market Review - The beauty and personal care index rose by 6.84% in August 2025, ranking 15th among all primary industries, underperforming the broader market which saw a 7.97% increase [12][15] - In the medical beauty sector, notable stock performances in August included Meili Tianyuan Medical Health (+32.4%), Kedi (+31.7%), and Yisi Health (+22.7%) [16] - In the cosmetics sector, leading performers were Jiaheng Home (+55.4%), Shuiyang Co. (+36.3%), and Ruoyu Chen (+29.0%) [20] 2. Medical Beauty - Jinbo Biological's "Recombinant Type III Humanized Collagen Freeze-Dried Fiber" received drug auxiliary material registration, marking a significant advancement in the medical field [26] - Longzi Co. plans to acquire 67.5% of Chongqing Milan Baiyu for 92.475 million yuan, with performance commitments ensuring net profits of at least 9.29 million yuan, 9.89 million yuan, and 11.83 million yuan from 2025 to 2027 [28] 3. Cosmetics - Proya plans to list in Hong Kong, potentially becoming the first A+H share beauty company, which would enhance its international business development [32] - Proya's investment in Huazhi Xiao will strengthen its position in the makeup sector, leveraging Huazhi Xiao's content operations and overseas channels [35] - The launch of the NAN beauty brand by Shangmei Co. represents a strategic move to enhance its presence in the mid-to-high-end market [40] 4. Investment Recommendations - The report recommends focusing on leading domestic beauty brands that are continuously evolving and capitalizing on high-growth segments [44] - Key recommendations include Shangmei Co., Maogeping, Proya, and Runben Co., with an emphasis on their strong market positions and growth potential [48]

Core Insights - The beauty industry in China is experiencing a significant performance divergence among leading companies, with a notable emphasis on quality improvement amidst a deep industry adjustment [1][2]. Group 1: Industry Performance - In the first half of 2025, retail sales of cosmetics in China increased by 2.9% year-on-year, with domestic brands capturing over 55% market share [2]. - Exports of cosmetics surged by 12% to 25.8 billion yuan, indicating strong overseas growth potential [2]. Group 2: Leading Companies - Leading companies like Proya, Mao Geping, and Shangmei continue to excel, while others like Huaxi Biological and Fulejia are lagging behind [2]. - Proya reported revenue of 5.362 billion yuan, a 7.21% increase, and a net profit of 799 million yuan, up 13.8% [4]. - Mao Geping achieved a revenue of 2.588 billion yuan, with a remarkable growth rate of 31.3%, and a net profit of 670 million yuan, reflecting a 36.1% increase [5]. - Shangmei's revenue reached 4.108 billion yuan, growing by 17.3%, with a net profit of 556 million yuan, up 34.7% [5]. - Juzhi Biological reported revenue of 3.113 billion yuan, a 22.5% increase, and a net profit of 1.182 billion yuan, up 20.2% [5]. Group 3: Underperforming Companies - Huaxi Biological reported a significant decline, with revenue dropping nearly 19.57% to 2.261 billion yuan and net profit falling 35.38% to 221 million yuan [6]. - Fulejia's revenue decreased by 8.15% to 863 million yuan, with a net profit decline of 32.54% to 230 million yuan, largely due to increased marketing expenses [9][11]. Group 4: Second-Tier Companies - Second-tier companies like Shanghai Jahwa, Marubi, and Shuiyang are showing improved performance [13]. - Shanghai Jahwa's revenue was 3.478 billion yuan, up 4.8%, with a net profit of 270 million yuan, increasing by 11.7% [14]. - Marubi achieved revenue of 1.769 billion yuan, a 30.83% increase, but net profit growth was only 5.21% [14]. - Shuiyang reported revenue of 2.5 billion yuan, a 9.02% increase, and a net profit of 123 million yuan, up 16.54% [14].

Core Viewpoint - The beauty industry in China is experiencing a significant performance divergence among leading companies, with a notable increase in quality, as evidenced by the half-year reports of domestic beauty brands [2]. Group 1: Leading Companies Performance - Leading beauty companies such as Proya, Mao Geping, and Shangmei continue to outperform, while Huaxi Biological and Fulejia are lagging behind [2][4]. - Proya reported a revenue of 5.362 billion yuan, a year-on-year increase of 7.21%, and a net profit of 799 million yuan, up 13.8%. However, its main brand experienced a slight revenue decline of 0.08% [5][6]. - Mao Geping, known as the "first stock of high-end domestic beauty," achieved a revenue of 2.588 billion yuan, with a net profit of 670 million yuan, both showing over 30% growth. The gross margin reached 84.2% [6]. - Shangmei's revenue was 4.108 billion yuan, growing 17.3%, with a net profit of 556 million yuan, up 34.7%. The "newpage" brand saw a revenue increase of 146.5% [6][7]. - Juzhi Biological reported a revenue of 3.113 billion yuan, a 22.5% increase, and a net profit of 1.182 billion yuan, up 20.2%, although growth rates have slowed compared to the previous year [7]. Group 2: Underperforming Companies - Huaxi Biological, referred to as the "first stock of hyaluronic acid," reported a revenue decline of 19.57% to 2.261 billion yuan and a net profit drop of 35.38% to 221 million yuan, marking its worst interim report since listing [9]. - The decline in Huaxi's revenue is attributed to a significant drop in its functional skincare business, which saw a 31.62% year-on-year decrease in 2024 [9]. - Fulejia's revenue was 863 million yuan, down 8.15%, with a net profit of 230 million yuan, a decrease of 32.54%. The company faced a substantial increase in sales expenses, which rose by 39.56% [11][12]. Group 3: Second-Tier Companies - Second-tier beauty companies such as Shanghai Jahwa, Marubi, and Shuiyang are showing improved performance [13][14]. - Shanghai Jahwa achieved a revenue of 3.478 billion yuan, a 4.75% increase, and a net profit of 266 million yuan, up 11.66%, attributed to online channel growth [15]. - Marubi reported a revenue of 1.769 billion yuan, a 30.83% increase, but its net profit only grew by 5.21%, indicating a potential profitability challenge [15][16]. - Shuiyang's revenue reached 2.5 billion yuan, a 9.02% increase, with a net profit of 123 million yuan, up 16.54%. The company is transitioning to a global high-end beauty brand management model [16].

Group 1 - The Guangdong Provincial High-tech Enterprise Association announced the first batch of outstanding high-tech products for 2025, with the domestic beauty brand Legend of Today’s Lipstick and Legend of Today’s Floral Essence both making the list, indicating official recognition of product innovation and showcasing the brand's advancement in technology research and development [1][3] - Legend of Today has been deeply engaged in the beauty industry for 21 years, viewing technological innovation as a core driving force, investing heavily in resources to build smart factories, and obtaining "National High-tech Enterprise" certification [3] - The brand has established the Legend of Today Research Institute and plans to collaborate with Beijing Technology and Business University to set up an "Innovation Technology Research Center" by the end of 2024, while its products are sold in over 70 countries and regions globally [3] Group 2 - In the context of the booming domestic beauty market, Legend of Today aims to continue focusing on innovative research and development, closely tracking global beauty technology trends, and increasing R&D investment to enhance product competitiveness [3] - With a strong brand foundation, ongoing independent innovation capabilities, and a commitment to excellence, Legend of Today is expected to play a more active leading role in advancing the globalization process of domestic beauty products towards higher quality and added value [3]

Core Viewpoint - The company reported strong performance in the first half of 2025, with significant revenue and profit growth, indicating a positive outlook for the business. Group 1: Overall Performance - In H1 2025, the company achieved revenue of 2.59 billion yuan, representing a year-on-year increase of 31% [1] - Net profit for H1 2025 reached 670 million yuan, up 36% year-on-year [1] - Gross margin stood at 84.2%, slightly down by 0.7 percentage points year-on-year, while net margin improved to 25.9%, up 0.9 percentage points [1] Group 2: Segment Performance - Makeup segment revenue in H1 2025 was 1.42 billion yuan, growing by 31.1% year-on-year, driven by strong sales of key products [2] - Skincare segment revenue reached 1.09 billion yuan, with a year-on-year increase of 33.4%, supported by high-performing products [2] - Fragrance segment generated revenue of 11.41 million yuan, showing strong performance from the "Wen Dao Dong Fang" series [2] - Makeup training revenue declined by 5.9% year-on-year to 67.31 million yuan [2] Group 3: Channel Performance - Offline revenue in H1 2025 was 1.224 billion yuan, up 26.6% year-on-year, with a total of 437 stores [3] - Online revenue reached 1.297 billion yuan, growing by 39% year-on-year, accounting for 51.4% of total revenue [3] - The company has 19 million members, a 53% increase year-on-year, with a repurchase rate of 26.8% [3] Group 4: Growth Drivers - The company is focusing on product innovation and international expansion, with new skincare and makeup lines launched in mid-2025 [3] - Plans for a research and development center in Hangzhou by the end of 2026 aim to support product diversification and market penetration [3] - The company is prioritizing entry into European and Asia-Pacific markets with localized teams and high-end channels [3] Group 5: Brand Positioning - The company is positioned as a leading domestic beauty brand, focusing on the mid-to-high-end makeup segment [4] - Strong brand premium and unique positioning in Oriental aesthetics contribute to long-term growth potential [4] - Profit forecasts for 2025-2027 are 1.184 billion, 1.542 billion, and 1.953 billion yuan, with corresponding PE ratios of 37, 29, and 23 [4]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1][6][22] Core Insights - The company has shown strong performance in the high-end domestic beauty market, with significant revenue growth and brand momentum [6][10] - The company reported a revenue of 2.59 billion RMB in H1 2025, representing a year-on-year increase of 31%, and a net profit of 670 million RMB, up 36% year-on-year [6][10] - The gross margin for H1 2025 was 84.2%, with a net profit margin of 25.9%, indicating effective cost control [6][10] Financial Data and Profit Forecast - Revenue projections for the company are as follows: - 2023: 2,886 million RMB - 2024: 3,885 million RMB - 2025E: 5,173 million RMB - 2026E: 6,852 million RMB - 2027E: 8,533 million RMB - Year-on-year growth rates for revenue are projected at 58% for 2023, 35% for 2024, and gradually decreasing to 25% by 2027 [5][13] - Net profit forecasts are as follows: - 2023: 662 million RMB - 2024: 881 million RMB - 2025E: 1,184 million RMB - 2026E: 1,542 million RMB - 2027E: 1,953 million RMB - The projected PE ratios are 64.7 for 2023, decreasing to 22.5 by 2027 [5][13] Segment Performance - The company experienced double-digit growth in both color cosmetics and skincare, with significant contributions from new product launches [6] - In H1 2025, color cosmetics revenue reached 1.42 billion RMB (up 31.1% YoY), while skincare revenue was 1.09 billion RMB (up 33.4% YoY) [6] - The fragrance segment also showed promising growth, with revenue of 11.41 million RMB, while the makeup training segment saw a decline of 5.9% [6] Channel Performance - The company has effectively released its potential across all channels, with offline revenue of 1.22 billion RMB (up 26.6% YoY) and online revenue of 1.297 billion RMB (up 39% YoY) [6] - The number of members reached 19 million, with a repurchase rate of 26.8%, indicating strong customer loyalty [6] Research and Development - The company is focused on innovation and international expansion, with new product launches planned and a research center set to support growth [6] - The company aims to penetrate the European and Asia-Pacific markets with localized teams and high-end channels [6] Brand Positioning - The company is positioned as a leading domestic beauty brand, capitalizing on the high-end color cosmetics market with a strong emphasis on unique aesthetics and product innovation [6]

Core Insights - The report from Yien Data indicates that the Chinese beauty market is experiencing steady growth and has entered a stable development phase, with domestic beauty brands rapidly gaining market share, projected to reach 55.2% by 2024, an increase of 2.9% from previous figures, surpassing foreign brands [1][11][13]. Group 1: Domestic Beauty Market Analysis - The domestic beauty market's social media presence remains robust, with a volume of 39.313 million and an interaction count of 485 million from August 2024 to July 2025, reflecting a 20% increase [1][14][16]. - The primary consumer demographic consists of women born in the 1990s, with nearly 30% of consumers being male; over 90% of consumers have purchased domestic beauty products, with younger consumers showing a higher preference for domestic brands [1][20][22]. Group 2: Domestic Skincare Market Insights - In the domestic skincare market, 80% of consumers are female, with 62% aged between 18-34, primarily located in high-tier cities. The demand for facial masks and serums is notably increasing, with brands like Proya leading in social media heat [2][36]. - Key consumer demands focus on anti-aging, repair, and whitening, with specific needs such as anti-aging eye creams and acne-controlling cleansers each accounting for 33% of consumer interest [2][35]. Group 3: Domestic Makeup Market Insights - The domestic makeup market also sees a significant female consumer base at 74%, with 68% aged 18-34, concentrated in high-tier cities. There is a rising interest in base makeup products, with a shift towards more advanced categories like blush and contour [2][36]. - The industry is witnessing three major trends: multifunctional products gaining popularity, a focus on niche markets, and a consensus on combining makeup and skincare functionalities [2][36]. Group 4: Emerging Trends in Domestic Beauty - The domestic skincare market is experiencing four key trends: the expansion of the men's skincare market, increased focus on Chinese ingredients, refined consumer demands, and the rise of short drama marketing strategies [2][36][38]. - The men's skincare market is projected to exceed 10 billion yuan, with brands launching dedicated product lines to capture this growing segment [2][39].